Login

Ownership

13F as of Q2 2026 · 31.4M shares outstanding

Who owns Cidara Therapeutics, Inc.?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Cidara Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2015–FY2024
+1180.1%
+32.75% a year
Each share's claim on the business
−92.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $42.5M
over 10 fiscal years
Diluted shares, split-adjusted
481.1K3.4M6.4M2015: 496.0K shares'152016: 724.4K shares'162017: 875.0K shares'172018: 1.3M shares'182019: 1.5M shares'192020: 2.1M shares'202021: 2.6M shares'212022: 3.5M shares'222023: 4.4M shares'232024: 6.3M shares'24
Buybacks Stock-based comp
$0$2.9M$5.7M2015 buybacks: $02015 stock comp: $3.0M'152016 buybacks: $02016 stock comp: $4.3M'162017 buybacks: $02017 stock comp: $5.7M'172018 buybacks: $02018 stock comp: $5.7M'182019 buybacks: $02019 stock comp: $5.1M'192020 buybacks: $02020 stock comp: $4.1M'202021 buybacks: $02021 stock comp: $4.0M'212022 buybacks: $02022 stock comp: $3.5M'222023 buybacks: $02023 stock comp: $3.1M'232024 buybacks: $02024 stock comp: $3.9M'24

How patient are the owners?

No 13F manager reports holding Cidara Therapeutics, Inc..

Super Investors

Investment managers reporting Cidara Therapeutics, Inc. on Form 13F
No 13F manager reports holding Cidara Therapeutics, Inc. yet.

Institutional Funds

Mutual funds and ETFs reporting Cidara Therapeutics, Inc. on Form N-PORT; together they hold 22.5% of the company
VT
Position value
$197M
% of company
2.84%
% of the fund
0.01%
As of
December 31, 2025
IR
iShares Trust
Position value
$110M
% of company
1.58%
% of the fund
0.15%
As of
December 31, 2025

23 more funds behind a free account

See every fund holding Cidara Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support